External Nasal Dilator Market By Application (Snoring, Sleep apnea, Nasal congestion, Others) , By End User (Adults, Pediatric) By Distribution Channel (Offline, Online) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The global external nasal dilator market was valued at $98.3 million in 2023, and is projected to reach $162.4 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033.
An external nasal dilator is an innovative device designed to enhance the nasal airflow by gently opening the nasal passages from the outside. This device is especially beneficial for people who have sleep apnea, nasal congestion, snoring, or who want to breathe better when exercising. An external nasal dilator is designed to alleviate airflow constraints to improve breathing and general health.
The growth of the global external nasal dilator market is driven by several factors such as surge in the prevalence of sleep apnea, increasing popularity and adoption of external nasal dilators for, nasal congestion, snoring, or who want to breathe better when exercising. In addition, allergies, colds, sinusitis, and anatomical anomalies are major causes of nasal congestion. Thus, by enlarging the nasal passageways, external nasal dilators provide a non-invasive way to relieve nasal congestion and facilitate better airflow and breathing. Furthermore, to monitor breathing patterns, sleep quality, and other metrics, certain external nasal dilators are incorporating sensors or networking elements in line with the growing trend of wearable health technology. Thus, end users can learn more about their overall respiratory health and nasal airflow from this data.
However, cost and accessibility of these dilators hinder the growth of the market. On the other hand, technological advancements, increasing prevalence of sleep apnea, snoring is expected to drive the external nasal dilator market opportunity. For instance, the global medical device manufacturer Rhinomed improves nasal medication administration, sleep quality, upper respiratory disease diagnostics, and respiration. By increasing airflow through the nose by 38% on average, MuteTM can lessen the frequency and intensity of snoring and improve both of your morning feelings of refreshment. According to user trials, snorers can sleep easily knowing that they're enhancing both the quality of their partner's sleep and their own breathing.
Segmentation Overview
The external nasal dilator market is segmented into application, end user, distribution channel, and region. Depending on the application, the market is divided into snoring, sleep apnea, nasal congestion, and others. As per end user, it is bifurcated into adults and pediatric. According to distribution channel, the market is classified into online channel and offline channel. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competitive Analysis
The major players operating in the external nasal dilator industry include GlaxoSmithKline Plc, HealthRight Products LLC, and Zhongshan Hongze Medical Technology Co., Ltd. Other players in the market are Permira I.P Limited, Health Right Products LLC, AirWare Labs., Splintek Inc, Scandinavian Formulas, Tomed GmbH, Creganna, Nasilator, Hubei YJT Technology Co., Ltd, Rhinomed Limited, Nasilator, Nasanita, SHREYAAS HEALTH CARE PVT LTD., and Walgreen Co. These companies have been active in adopting different tactics to maintain their position in the competitive market.
Key Market Segments
By Application
Snoring
Sleep apnea
Nasal congestion
Others
By End User
Adults
Pediatric
By Distribution Channel
Offline
Online
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
GlaxoSmithKline Plc
HealthRight Products LLC
Zhongshan Hongze Medical Technology Co., Ltd.
Permira I.P Limited
Health Right Products LLC
AirWare Labs
Splintek Inc
Scandinavian Formulas
Tomed GmbH
Rhinomed Limited
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: EXTERNAL NASAL DILATOR MARKET, BY APPLICATION
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Application
- 4.2. Snoring
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Sleep Apnea
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Nasal Congestion
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Others
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: EXTERNAL NASAL DILATOR MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Adults
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Pediatric
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Distribution Channel
- 6.2. Offline
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Online
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- CHAPTER 7: EXTERNAL NASAL DILATOR MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Application
- 7.2.3. Market Size and Forecast, By End User
- 7.2.4. Market Size and Forecast, By Distribution Channel
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. External Nasal Dilator Market
- 7.2.6.1. Market Size and Forecast, By Application
- 7.2.6.2. Market Size and Forecast, By End User
- 7.2.6.3. Market Size and Forecast, By Distribution Channel
- 7.2.7. Canada External Nasal Dilator Market
- 7.2.7.1. Market Size and Forecast, By Application
- 7.2.7.2. Market Size and Forecast, By End User
- 7.2.7.3. Market Size and Forecast, By Distribution Channel
- 7.2.8. Mexico External Nasal Dilator Market
- 7.2.8.1. Market Size and Forecast, By Application
- 7.2.8.2. Market Size and Forecast, By End User
- 7.2.8.3. Market Size and Forecast, By Distribution Channel
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Application
- 7.3.3. Market Size and Forecast, By End User
- 7.3.4. Market Size and Forecast, By Distribution Channel
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France External Nasal Dilator Market
- 7.3.6.1. Market Size and Forecast, By Application
- 7.3.6.2. Market Size and Forecast, By End User
- 7.3.6.3. Market Size and Forecast, By Distribution Channel
- 7.3.7. Germany External Nasal Dilator Market
- 7.3.7.1. Market Size and Forecast, By Application
- 7.3.7.2. Market Size and Forecast, By End User
- 7.3.7.3. Market Size and Forecast, By Distribution Channel
- 7.3.8. Italy External Nasal Dilator Market
- 7.3.8.1. Market Size and Forecast, By Application
- 7.3.8.2. Market Size and Forecast, By End User
- 7.3.8.3. Market Size and Forecast, By Distribution Channel
- 7.3.9. Spain External Nasal Dilator Market
- 7.3.9.1. Market Size and Forecast, By Application
- 7.3.9.2. Market Size and Forecast, By End User
- 7.3.9.3. Market Size and Forecast, By Distribution Channel
- 7.3.10. UK External Nasal Dilator Market
- 7.3.10.1. Market Size and Forecast, By Application
- 7.3.10.2. Market Size and Forecast, By End User
- 7.3.10.3. Market Size and Forecast, By Distribution Channel
- 7.3.11. Rest Of Europe External Nasal Dilator Market
- 7.3.11.1. Market Size and Forecast, By Application
- 7.3.11.2. Market Size and Forecast, By End User
- 7.3.11.3. Market Size and Forecast, By Distribution Channel
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Application
- 7.4.3. Market Size and Forecast, By End User
- 7.4.4. Market Size and Forecast, By Distribution Channel
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China External Nasal Dilator Market
- 7.4.6.1. Market Size and Forecast, By Application
- 7.4.6.2. Market Size and Forecast, By End User
- 7.4.6.3. Market Size and Forecast, By Distribution Channel
- 7.4.7. Japan External Nasal Dilator Market
- 7.4.7.1. Market Size and Forecast, By Application
- 7.4.7.2. Market Size and Forecast, By End User
- 7.4.7.3. Market Size and Forecast, By Distribution Channel
- 7.4.8. India External Nasal Dilator Market
- 7.4.8.1. Market Size and Forecast, By Application
- 7.4.8.2. Market Size and Forecast, By End User
- 7.4.8.3. Market Size and Forecast, By Distribution Channel
- 7.4.9. South Korea External Nasal Dilator Market
- 7.4.9.1. Market Size and Forecast, By Application
- 7.4.9.2. Market Size and Forecast, By End User
- 7.4.9.3. Market Size and Forecast, By Distribution Channel
- 7.4.10. Australia External Nasal Dilator Market
- 7.4.10.1. Market Size and Forecast, By Application
- 7.4.10.2. Market Size and Forecast, By End User
- 7.4.10.3. Market Size and Forecast, By Distribution Channel
- 7.4.11. Rest of Asia-Pacific External Nasal Dilator Market
- 7.4.11.1. Market Size and Forecast, By Application
- 7.4.11.2. Market Size and Forecast, By End User
- 7.4.11.3. Market Size and Forecast, By Distribution Channel
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Application
- 7.5.3. Market Size and Forecast, By End User
- 7.5.4. Market Size and Forecast, By Distribution Channel
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil External Nasal Dilator Market
- 7.5.6.1. Market Size and Forecast, By Application
- 7.5.6.2. Market Size and Forecast, By End User
- 7.5.6.3. Market Size and Forecast, By Distribution Channel
- 7.5.7. South Africa External Nasal Dilator Market
- 7.5.7.1. Market Size and Forecast, By Application
- 7.5.7.2. Market Size and Forecast, By End User
- 7.5.7.3. Market Size and Forecast, By Distribution Channel
- 7.5.8. Saudi Arabia External Nasal Dilator Market
- 7.5.8.1. Market Size and Forecast, By Application
- 7.5.8.2. Market Size and Forecast, By End User
- 7.5.8.3. Market Size and Forecast, By Distribution Channel
- 7.5.9. Rest of LAMEA External Nasal Dilator Market
- 7.5.9.1. Market Size and Forecast, By Application
- 7.5.9.2. Market Size and Forecast, By End User
- 7.5.9.3. Market Size and Forecast, By Distribution Channel
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. GlaxoSmithKline Plc
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. HealthRight Products LLC
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Zhongshan Hongze Medical Technology Co., Ltd.
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Permira I.P Limited
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Health Right Products LLC
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. AirWare Labs
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Splintek Inc
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Scandinavian Formulas
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Tomed GmbH
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Rhinomed Limited
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 2. EXTERNAL NASAL DILATOR MARKET FOR SNORING, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. EXTERNAL NASAL DILATOR MARKET FOR SLEEP APNEA, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. EXTERNAL NASAL DILATOR MARKET FOR NASAL CONGESTION, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 5. EXTERNAL NASAL DILATOR MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 6. GLOBAL EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 7. EXTERNAL NASAL DILATOR MARKET FOR ADULTS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 8. EXTERNAL NASAL DILATOR MARKET FOR PEDIATRIC, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 9. GLOBAL EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 10. EXTERNAL NASAL DILATOR MARKET FOR OFFLINE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 11. EXTERNAL NASAL DILATOR MARKET FOR ONLINE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 12. EXTERNAL NASAL DILATOR MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 13. NORTH AMERICA EXTERNAL NASAL DILATOR MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 14. NORTH AMERICA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 15. NORTH AMERICA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 16. NORTH AMERICA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 17. U.S. EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 18. U.S. EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 19. U.S. EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 20. CANADA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 21. CANADA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 22. CANADA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 23. MEXICO EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 24. MEXICO EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 25. MEXICO EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 26. EUROPE EXTERNAL NASAL DILATOR MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 27. EUROPE EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 28. EUROPE EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 29. EUROPE EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 30. FRANCE EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 31. FRANCE EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 32. FRANCE EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 33. GERMANY EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 34. GERMANY EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 35. GERMANY EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 36. ITALY EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 37. ITALY EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 38. ITALY EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 39. SPAIN EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 40. SPAIN EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 41. SPAIN EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 42. UK EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 43. UK EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 44. UK EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 45. REST OF EUROPE EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 46. REST OF EUROPE EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 47. REST OF EUROPE EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 48. ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 49. ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 50. ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 51. ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 52. CHINA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 53. CHINA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 54. CHINA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 55. JAPAN EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 56. JAPAN EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 57. JAPAN EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 58. INDIA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 59. INDIA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 60. INDIA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 61. SOUTH KOREA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 62. SOUTH KOREA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 63. SOUTH KOREA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 64. AUSTRALIA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 65. AUSTRALIA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 66. AUSTRALIA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 70. LAMEA EXTERNAL NASAL DILATOR MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 71. LAMEA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 72. LAMEA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 73. LAMEA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 74. BRAZIL EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 75. BRAZIL EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 76. BRAZIL EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 77. SOUTH AFRICA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 78. SOUTH AFRICA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 79. SOUTH AFRICA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 80. SAUDI ARABIA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 81. SAUDI ARABIA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 82. SAUDI ARABIA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 83. REST OF LAMEA EXTERNAL NASAL DILATOR MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 84. REST OF LAMEA EXTERNAL NASAL DILATOR MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 85. REST OF LAMEA EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL, 2024 - 2033 ($MILLION)
- TABLE 86. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
- TABLE 87. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
- TABLE 88. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
- TABLE 89. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
- TABLE 90. GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 91. HEALTHRIGHT PRODUCTS LLC: KEY EXECUTIVES
- TABLE 92. HEALTHRIGHT PRODUCTS LLC: COMPANY SNAPSHOT
- TABLE 93. HEALTHRIGHT PRODUCTS LLC: OPERATING SEGMENTS
- TABLE 94. HEALTHRIGHT PRODUCTS LLC: PRODUCT PORTFOLIO
- TABLE 95. HEALTHRIGHT PRODUCTS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: KEY EXECUTIVES
- TABLE 97. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
- TABLE 98. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: OPERATING SEGMENTS
- TABLE 99. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
- TABLE 100. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. PERMIRA I.P LIMITED: KEY EXECUTIVES
- TABLE 102. PERMIRA I.P LIMITED: COMPANY SNAPSHOT
- TABLE 103. PERMIRA I.P LIMITED: OPERATING SEGMENTS
- TABLE 104. PERMIRA I.P LIMITED: PRODUCT PORTFOLIO
- TABLE 105. PERMIRA I.P LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. HEALTH RIGHT PRODUCTS LLC: KEY EXECUTIVES
- TABLE 107. HEALTH RIGHT PRODUCTS LLC: COMPANY SNAPSHOT
- TABLE 108. HEALTH RIGHT PRODUCTS LLC: OPERATING SEGMENTS
- TABLE 109. HEALTH RIGHT PRODUCTS LLC: PRODUCT PORTFOLIO
- TABLE 110. HEALTH RIGHT PRODUCTS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. AIRWARE LABS: KEY EXECUTIVES
- TABLE 112. AIRWARE LABS: COMPANY SNAPSHOT
- TABLE 113. AIRWARE LABS: OPERATING SEGMENTS
- TABLE 114. AIRWARE LABS: PRODUCT PORTFOLIO
- TABLE 115. AIRWARE LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 116. SPLINTEK INC: KEY EXECUTIVES
- TABLE 117. SPLINTEK INC: COMPANY SNAPSHOT
- TABLE 118. SPLINTEK INC: OPERATING SEGMENTS
- TABLE 119. SPLINTEK INC: PRODUCT PORTFOLIO
- TABLE 120. SPLINTEK INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121. SCANDINAVIAN FORMULAS: KEY EXECUTIVES
- TABLE 122. SCANDINAVIAN FORMULAS: COMPANY SNAPSHOT
- TABLE 123. SCANDINAVIAN FORMULAS: OPERATING SEGMENTS
- TABLE 124. SCANDINAVIAN FORMULAS: PRODUCT PORTFOLIO
- TABLE 125. SCANDINAVIAN FORMULAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 126. TOMED GMBH: KEY EXECUTIVES
- TABLE 127. TOMED GMBH: COMPANY SNAPSHOT
- TABLE 128. TOMED GMBH: OPERATING SEGMENTS
- TABLE 129. TOMED GMBH: PRODUCT PORTFOLIO
- TABLE 130. TOMED GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 131. RHINOMED LIMITED: KEY EXECUTIVES
- TABLE 132. RHINOMED LIMITED: COMPANY SNAPSHOT
- TABLE 133. RHINOMED LIMITED: OPERATING SEGMENTS
- TABLE 134. RHINOMED LIMITED: PRODUCT PORTFOLIO
- TABLE 135. RHINOMED LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL EXTERNAL NASAL DILATOR MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF EXTERNAL NASAL DILATOR MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN EXTERNAL NASAL DILATOR MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEXTERNAL NASAL DILATOR MARKET
- FIGURE 10. GLOBAL EXTERNAL NASAL DILATOR MARKET SEGMENTATION, BY APPLICATION
- FIGURE 11. EXTERNAL NASAL DILATOR MARKET FOR SNORING, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 12. EXTERNAL NASAL DILATOR MARKET FOR SLEEP APNEA, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. EXTERNAL NASAL DILATOR MARKET FOR NASAL CONGESTION, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 14. EXTERNAL NASAL DILATOR MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 15. GLOBAL EXTERNAL NASAL DILATOR MARKET SEGMENTATION, BY END USER
- FIGURE 16. EXTERNAL NASAL DILATOR MARKET FOR ADULTS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. EXTERNAL NASAL DILATOR MARKET FOR PEDIATRIC, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 18. GLOBAL EXTERNAL NASAL DILATOR MARKET SEGMENTATION, BY DISTRIBUTION CHANNEL
- FIGURE 19. EXTERNAL NASAL DILATOR MARKET FOR OFFLINE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 20. EXTERNAL NASAL DILATOR MARKET FOR ONLINE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 25. COMPETITIVE DASHBOARD
- FIGURE 26. COMPETITIVE HEATMAP: EXTERNAL NASAL DILATOR MARKET
- FIGURE 27. TOP PLAYER POSITIONING, 2023
- FIGURE 28. GLAXOSMITHKLINE PLC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 29. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. HEALTHRIGHT PRODUCTS LLC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 32. HEALTHRIGHT PRODUCTS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. HEALTHRIGHT PRODUCTS LLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 35. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. ZHONGSHAN HONGZE MEDICAL TECHNOLOGY CO., LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. PERMIRA I.P LIMITED: NET SALES, 2021-2023 ($MILLION)
- FIGURE 38. PERMIRA I.P LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. PERMIRA I.P LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. HEALTH RIGHT PRODUCTS LLC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 41. HEALTH RIGHT PRODUCTS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. HEALTH RIGHT PRODUCTS LLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. AIRWARE LABS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 44. AIRWARE LABS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. AIRWARE LABS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. SPLINTEK INC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 47. SPLINTEK INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. SPLINTEK INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. SCANDINAVIAN FORMULAS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 50. SCANDINAVIAN FORMULAS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. SCANDINAVIAN FORMULAS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. TOMED GMBH: NET SALES, 2021-2023 ($MILLION)
- FIGURE 53. TOMED GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. TOMED GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. RHINOMED LIMITED: NET SALES, 2021-2023 ($MILLION)
- FIGURE 56. RHINOMED LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. RHINOMED LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook